北京健康:年報2023
Beijing Health (02389) Announces 2023 Results Loss attributable to parent company owners of HK$61.882 million narrowed 36.66% year-on-year
According to the Zhitong Finance App, Beijing Health (02389) announced its 2023 results, with revenue of about HK$140 million, a year-on-year decrease of 15.7%; parent company owners should have accounted for a loss of HK$61.882 million, a year-on-year decrease of 36.66%; and a loss of 1.01 HK cents per share. According to the announcement, the decline in revenue was mainly due to an 18.5% decrease in sales revenue of medical products to HK$128.6 million. The main customer source for the Healthcare Products Division comes mostly from tender orders from enterprises and institutions. The cycle from winning the bid to delivery of the product is about half a year to one year. Due to the second half of 2022, China is still affected by the COVID-19 pandemic
BJ HEALTH: ANNOUNCEMENT OF THE ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Beijing Health (02389.HK) plans to hold a board meeting on March 28 to approve annual results
Gelonghui, March 1, 丨 Beijing Health (02389.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to consider and approve the Group's annual results for the year ended December 31, 2023, pay a final dividend (if any), and deal with other matters.
Beijing Health (02389): Hu Xiangqi Resigns as Executive Director
Zhitong Finance App News, Beijing Health (02389) issued an announcement. Hu Xiangqi has proposed the resignation of the company's executive director, effective February 29, 2024; Zhao Gang has proposed to resign as an independent non-executive director of the company, effective February 29, 2024; and Kang Shixue has proposed to resign as an independent non-executive director of the company, effective February 29, 2024. The reasons are all due to the need to invest more time in other personal matters.
Huatai Securities: The silver economy may spawn a series of investment opportunities from the capital side, demand side, and supply side
As China's aging deepens, the introduction of the first banking economic policy may spawn a series of investment opportunities from the demand side, supply side, and capital side.
Beijing Health (02389.HK) purchases acceptance notes
Gelonghui, January 31, 丨 Beijing Health (02389.HK) announced that on January 31, 2024, the company used its internal resources to purchase acceptance notes (“acceptance note I”) issued by the issuer with an amount of 4.28 million Canadian dollars. Additionally, on January 2, 2024, the Company used its internal resources to purchase acceptance notes (“Acceptance Notes II”) issued by the issuer in the amount of 3 million Canadian dollars. Promissory Note I and Promissory Note I issuer 813 Carnarvon Street Developments Limited Partnership is a company in
Beijing Health (02389) will cooperate with the Cultural Tourism Group to renovate the ancient canal cultural and creative building
Beijing Health (02389) announced that on November 10, 2023, the group and Liangxi Cultural Tourism Development in Wuxi City...
Luo Xin Pharmaceutical (002793.SZ): Plans to transfer part of the shares in Beijing Health and increase its capital
Gelonghui, October 13丨Luo Xin Pharmaceutical (002793.SZ) announced that the company holds 51% of the shares of the holding subsidiary Luo Xin Health Technology Development (Beijing) Co., Ltd. (“Beijing Health” and “target company” for short) (corresponding to the registered capital of the target company of 116.23 million yuan). Another shareholder of Beijing Health, Chengdu Deyi Xinhua Equity Investment Partnership (Limited Partnership) (“Chengdu Deyi” for short) holds 49% of Beijing Health's shares (corresponding to the registered capital of the target company is 111.67 million yuan, the actual payment amount is RMB 67.37 million, and the actual payment ratio is 36.69%). Chengdu Deyi plans to play
BJ HEALTH: INTERIM REPORT 2023
Trending Industry Today: SINO-OCEAN GP Leads Gains In Retirement Concept Stocks
September 6th - The industry of $Retirement Concept(BK1335.HK)$ is trending higher today with 5 constituents up, 1 constituents down and SINO-OCEAN GP leading Gains.$SINO-OCEAN GP(03377.HK)$ rises 17.
BJ HEALTH: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2022
Beijing Health (02389) granted 21 million yuan in short-term loan financing
Beijing Health (02389) issued an announcement. On August 30, 2023, the lender (a non-wholly owned subsidiary of the company, North...
Beijing Health (02389) announced its interim results, loss of HK$1,832 million decreased by 48% year-on-year
Beijing Health (02389) announced the results for the first half of 2023. The company achieved a year-on-year decrease of 15.0% in revenue to 7...
BJ HEALTH: ANNOUNCEMENT OF THE INTERIM RESULTS FOR THE PERIOD ENDED 30 JUNE 2023
Beijing Health (02389.HK) will hold a board meeting on August 29 to approve interim results
On August 3, GLONGHUI, BEIJING HEALTH (02389.HK) announced that the company will hold a board meeting on August 29, 2023 to consider and approve the interim results and announcements of the company and its subsidiaries for the six months ended June 30, 2023, and consider the payment of interim dividends (if any).
BJ HEALTH: Date of Board Meeting
Beijing Health: Annual Report 2022
Beijing Health: Annual Results Announcement for the Year Ended December 31, 2022
Beijing Health: interim report 2022
No Data